Of note, tPA and TAFI levels were elevated in patients with COVID‐19 disease compared with healthy controls (p < .001 and p < .05, respectively) but were not different compared with non‐COVID‐19 respiratory infection (Figure 2C,F). The gene discussed is CPB2; the disease is respiratory tract infectious disorder.